However, the primary research paper often cited by that community regarding the drug's potential anti-cancer mechanisms is:

It promotes the activation of the p53 tumor suppressor protein, leading to programmed cell death (apoptosis). Other Notable Papers

An overview of the pharmacokinetics and promising biological activities for cancer therapy in both humans and animals. Oral Fenbendazole for Cancer Therapy .

Research indicating that the drug may target cancer stem cells, which are often resistant to standard treatments. Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer .